However, their findings also suggested that ERG fusion is not required for PTEN loss to determine aggressive tumor behavior, because PTEN deletion in both ERG fusion-positive and fusion-negative cancers was independently linked to poor prognosis, while the presence of ERG fusion was unrelated to patient prognosis (40). The gene discussed is ERG; the disease is cancer.